Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer
Clinical trial NCT07731607 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07731607
- Sponsor
- Wang Jianliu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2030-07-20
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.